Results 91 to 100 of about 22,449 (147)
Pharmacological interventions for alcohol use disorder: novel insights from recent clinical trials. [PDF]
McManus KR, Ray LA.
europepmc +1 more source
Pruritus associated with systemic sclerosis: a systematic review of treatment-based clinical trials. [PDF]
Mortezaei K +9 more
europepmc +1 more source
Case report: the challenges of psychogenic polydipsia. [PDF]
Raha A, Mordekar A.
europepmc +1 more source
Erratum: Pain Intensity in Patients with Opioid Use Disorder on Extended-Release Naltrexone or Opioid Agonists; The Role of COMT rs4680 and OPRM1 rs1799971: An Exploratory Study [Corrigendum]. [PDF]
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Reactions Weekly, 2023
Abstract Use of opioid antagonists, particularly when delivered as an extended-release formulation, is a meaningful treatment option for individuals with opioid use disorder who are highly motivated to remain opioid abstinent or do not have access to agonist treatment.
Marina Tsoy-Podosenin, Evgeny Krupitsky
+4 more sources
Abstract Use of opioid antagonists, particularly when delivered as an extended-release formulation, is a meaningful treatment option for individuals with opioid use disorder who are highly motivated to remain opioid abstinent or do not have access to agonist treatment.
Marina Tsoy-Podosenin, Evgeny Krupitsky
+4 more sources
Blood naltrexone levels over time following naltrexone implant [PDF]
Aims: Oral naltrexone is used in the management of both heroin and alcohol dependence. However, poor compliance has limited its clinical utility. The study\u27s objective was to determine the period of therapeutic coverage (≥ 2 ng/ml) provided by a 3.3 g
Gary Hulse, Robert J Tait
exaly +3 more sources
Naltrexone and Conventionality
The American Journal of Drug and Alcohol Abuse, 1978This study examines the effect of conventionality on whether patients who were scheduled for naltrexone took it, and on treatment outcomes for patients who did take it. It is based on admission and case record data for 147 male opiate addicts who enrolled in New York Medical College's Multitrack Abstinence Program. Naltrexone-taking is examined against
F, Suffet +3 more
openaire +2 more sources

